Skip to main content
Clinical Trials/NCT05539937
NCT05539937
Recruiting
Not Applicable

Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis. (TAVI QdV)

Elsan1 site in 1 country140 target enrollmentMarch 21, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Quality of Life
Sponsor
Elsan
Enrollment
140
Locations
1
Primary Endpoint
Change in the TASQ global score 12 months after TAVI compared to the TASQ global score before TAVI
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

In order to overcome the shortcomings of the assessment questionnaires currently available on the assessment of overall quality of life, the "Toronto Aortic Stenosis Quality of Life Questionnaire" (TASQ) was developed as a specific assessment tool for the impact of severe aortic stenosis in elderly patients, through 16 questions covering 5 domains: symptoms and physical limitations, emotional impact and expectations following TAVI, as well as social limitations incurred.

A better knowledge and understanding of the clinical outcomes and quality of life of elderly patients with severe symptomatic aortic stenosis at 12 months of follow-up of a TAVI procedure would further optimize the clinical decision-making process and patient selection who will benefit the most from this intervention in the long term.

Registry
clinicaltrials.gov
Start Date
March 21, 2023
End Date
March 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Elsan
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male, female, over 18 years old,
  • All patients who will have transfemoral percutaneous aortic valve replacement (TAVI) with implantation of a valve delivered on a balloon,
  • Patient able to understand the study, and answer the TASQ questionnaire,
  • Affiliation to a social security scheme or beneficiary of such a scheme,
  • Patient having signed the free and informed consent.

Exclusion Criteria

  • Disorder of comprehension and/or expression,
  • Patients unable to answer questions due to an underlying cognitive deficit or physical disability,
  • Patients treated with a self-expanding valve,
  • Refusal to participate in the study,
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision,
  • Pregnant, parturient, or breast-feeding patient.

Outcomes

Primary Outcomes

Change in the TASQ global score 12 months after TAVI compared to the TASQ global score before TAVI

Time Frame: 12 months

Study Sites (1)

Loading locations...

Similar Trials